NBT
ABBV icon

Northwest Bank & Trust’s AbbVie ABBV Stock Holding History

Northwest Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$128K Hold
700
– – 0.09% 95
2024
Q3 		$138K Hold
700
– – 0.11% 95
2024
Q2 		$120K Hold
700
– – 0.1% 98
2024
Q1 		$114K Sell
700
-86
-11% -$14.8K 0.1% 95
2023
Q4 		$122K Buy
+786
New +$115K 0.11% 97
2023
Q2 		$106K Buy
+786
New +$115K 0.1% 91

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northwest Bank & Trust's ABBV Position: Q4 2024 in Review

Northwest Bank & Trust held its AbbVie (ABBV) position steady in Q4 2024 at 700 shares worth $128K. The position accounts for 0.09% of the portfolio, ranked #95.

Northwest Bank & Trust first reported a position in ABBV in Q2 2023 and has held it in 6 quarters since. The position peaked at $138K in Q3 2024. 3,750 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Northwest Bank & Trust held 700 shares of AbbVie worth $128K as of Q4 2024.
  • Northwest Bank & Trust left its AbbVie share count unchanged in Q4 2024.
  • AbbVie made up 0.09% of Northwest Bank & Trust's portfolio in Q4 2024, its #95 holding.
  • Northwest Bank & Trust first reported a position in AbbVie in Q2 2023 and has held it in 6 quarters since.
  • Northwest Bank & Trust's AbbVie position peaked at $138K in Q3 2024.
  • 3,750 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.